Alkanes are saturated hydrocarbons that serve as available and cost-effective feedstock for producing alkenes, key intermediates in numerous industrial processes. A mutant bacterial strain, Rhodococcus sp. KSM-B-3M, was previously reported to efficiently convert alkanes into alkenes and was later utilized by us to selectively transform linear alkanes into a variety of alkyl derivatives through a two-step process. Here, we explored the biological mechanisms underlying the unique biotransformation capability of strain KSM-B-3M by integrating genomics, transcriptomics, proteomics, and 3D-structural modelling. Strain KSM-B-3M demonstrated downregulation of the fatty acid degradation pathway, lacking the pR8L1 megaplasmid that carries multiple fatty acid degradation genes, accompanied by a parallel high expression of the acyl CoA-desaturase gene. Partial curing of the pR8L1 plasmid from a wild-type (WT) strain conferred the ability to dehydrogenate n-hexadecane to cis-hexadecene. Overexpression of the acyl-CoA desaturase gene similarly induced cis-hexadecene formation in the WT strain, acting cumulatively with fatty acid degradation downregulation. Acyl CoA-desaturase 3-D modeling suggested that the enzyme directly dehydrogenates n-hexadecane to form cis-hexadecene, supporting its direct role in this unique biotransformation. These findings advance our understanding of the mechanism behind this biotransformation, which holds promise for sustainable and cost-effective production of alkyl derivatives.
Edri et al. (Tue,) studied this question.